Shanna Fuld

About the Author Shanna Fuld

Shanna J. Fuld is a journalist specializing in finance. Born and raised in Queens, New York, she’s been avoiding dates with finance guys for years – only to find herself becoming one. The former NY1er worked as a videographer, assignment editor and writer for the beloved local news channel before joining the Smarter Analyst team.

Advanced Micro Devices (AMD) CEO Wows the Crowd; Rosenblatt Reiterates Buy on the Stock

The CES conference in Las Vegas wraps up tomorrow and by the way the room reacted to Advanced Micro Devices’ (AMD) Chief Executive …

Will Aphria (APHA) Earnings Make or Break the Stock?

Ahead of Aphria’s (APHA) second quarter fiscal 2019 earnings, which are set to be released on Friday, January 11, cannabis research team Cornerstone Investments (CI) …

Don’t Say Bye Bye to Apple (AAPL) Stock, Say Buy Buy

The most important news of last week, of course, was Apple’s warning about sluggish performance. As a reminder, the tech giant has warned investors that revenue would …

Micron (MU) Stock: Breaking Down BMO’s New Bullish Call

It seems like black clouds are rolling in over Micron (MU). In December, the company reported a slowdown in revenue and a drop in …

Bullish Analyst Ups Price Target on Axsome (AXSM) Stock as It Gets Closer in Bringing MDD Drug to Market

Axsome Therapeutics (AXSM) stock more than doubled since the drug maker announced positive results for its phase 2 trial, ASCEND on Monday. The …

2019 Could Be a Breakout Year for New Age Beverages (NBEV) Stock

The cannabis industry grew to new heights in 2018, causing companies like New Age Beverages Corporation (NBEV) to launch a new line of …

Why Amarin (AMRN) Stock May Be a Good Buy Right Now

Amarin (AMRN) has had a lot of attention over its fish oil pill Vascepa, which aims to help those with cardiovascular problems and …

La Jolla (LJPC) Stock Crashes — Is There a Light at the End of the Tunnel?

La Jolla’s (LJPC) shares lost almost half of their value Monday, after the company pre-announced fourth quarter revenues for its drug Giapreza – …

Analyst Cuts Price Target on Aphria (APHA) Stock Amid Recent Takeover Talks

Aphria (APHA) stock has been experiencing some turbulence ever since a short report came out in early December suggesting the company was benefiting …

Why This Analyst Bets on Amazon (AMZN) Stock

What would you tell someone if they were to ask you, “Should I buy Amazon (AMZN) right now?” After all, Amazon stock is still …